Risk-adjusted survival after treatment decision for clinically staged (c), pathologically staged (p), and posttreatment pathologically staged (yp) esophageal squamous cell cancer
Risk-adjusted survival after treatment decision for clinically staged (c), pathologically staged (p), and posttreatment pathologically staged (yp) esophageal squamous cell cancer
(A) Risk-adjusted survival after treatment decision for clinically staged (c) squamous cell carcinoma of the esophagus based on Worldwide Esophageal Cancer Collaboration (WECC) data. (B) Risk-adjusted survival after treatment decision for pathologically staged (p) squamous cell carcinoma of the esophagus based on WECC data. (C) Risk-adjusted survival after treatment decision for postneoadjuvant pathologically staged (yp) squamous cell carcinoma of the esophagus based on WECC data.
Used with permission of the American College of Surgeons, Chicago, Illinois. The original source for this information is the AJCC Cancer Staging Manual, Eighth Edition (2017) published by Springer International Publishing.
